Home
Data
Calendar
Blog
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Value | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | NA | 0.00 | NA | NA | |
| Weighted Average Number Of Diluted Shares Outstanding | 145.79 | NA | 144.70 | 144.40 | 143.51 | NA | 142.93 | 142.36 | 141.70 | NA | 140.83 | 140.36 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Weighted Average Number Of Shares Outstanding Basic | 145.79 | NA | 144.70 | 144.40 | 143.51 | NA | 142.93 | 142.36 | 141.70 | NA | 140.83 | 140.36 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Earnings Per Share Basic | -0.33 | -0.48 | -0.35 | -0.33 | -0.40 | -0.28 | -0.32 | -0.37 | -0.44 | -0.44 | -0.40 | -0.35 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Earnings Per Share Diluted | -0.33 | -0.48 | -0.35 | -0.33 | -0.40 | -0.28 | -0.32 | -0.37 | -0.44 | -0.44 | -0.40 | -0.35 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue From Contract With Customer Excluding Assessed Tax | 41.87 | 45.78 | 37.92 | 48.93 | 37.65 | 55.20 | 47.83 | 43.66 | 38.62 | 37.93 | 39.47 | 38.51 | 38.44 | 30.18 | 26.30 | 20.99 | 20.91 | 24.21 | 26.06 | 22.14 | 12.67 | 17.19 | 17.19 | 11.57 | |
| Revenues | 41.87 | 45.78 | 37.92 | 48.93 | 37.65 | 55.20 | 47.83 | 43.66 | 38.62 | 37.93 | 39.47 | 38.51 | 38.44 | 30.18 | 26.30 | 20.99 | 20.91 | 24.21 | 26.06 | 22.14 | 12.67 | 17.19 | 17.19 | 11.57 | |
| Cost Of Goods And Services Sold | 18.05 | 19.62 | 19.35 | 17.91 | 18.68 | 16.59 | 14.91 | 13.22 | 13.19 | 14.36 | 14.19 | 10.77 | 9.99 | 6.22 | 6.05 | 4.91 | 5.34 | 5.95 | 5.60 | 5.73 | 4.99 | 5.28 | 5.36 | 5.04 | |
| Costs And Expenses | 90.64 | 116.85 | 88.88 | 96.74 | 94.84 | 94.38 | 93.26 | 96.16 | 101.69 | 99.53 | 95.79 | 88.27 | 79.72 | 74.42 | 63.35 | 57.90 | 55.53 | 48.40 | 44.11 | 38.24 | 32.71 | 31.34 | 26.35 | 24.88 | |
| Research And Development Expense | 30.25 | 28.75 | 28.53 | 32.24 | 32.60 | 31.22 | 35.66 | 37.04 | 37.84 | 34.70 | 36.07 | 37.80 | 33.77 | 35.83 | 30.31 | 25.99 | 23.93 | 21.19 | 20.51 | 16.53 | 12.48 | 11.07 | 9.78 | 9.45 | |
| General And Administrative Expense | 19.60 | 20.73 | 20.07 | 22.30 | 20.83 | 22.43 | 20.75 | 21.20 | 24.14 | 23.35 | 20.15 | 16.07 | 14.94 | 13.40 | 12.08 | 12.24 | 11.82 | 8.19 | 8.48 | 6.66 | 7.00 | 6.50 | 4.74 | 4.63 | |
| Selling And Marketing Expense | 22.32 | 21.91 | 20.49 | 23.87 | 22.31 | 23.72 | 21.51 | 24.28 | 26.09 | 26.70 | 24.95 | 23.22 | 20.60 | 18.55 | 14.47 | 14.33 | 14.01 | 12.64 | 9.10 | 8.90 | 7.82 | 8.07 | 6.04 | 5.33 | |
| Operating Income Loss | -48.76 | -71.07 | -50.96 | -47.82 | -57.19 | -39.19 | -45.43 | -52.50 | -63.07 | -61.60 | -56.33 | -49.77 | -41.28 | -44.24 | -37.05 | -36.91 | -34.62 | -24.19 | -18.05 | -16.11 | -20.05 | -14.14 | -9.16 | -13.31 | |
| Interest Expense | 2.99 | 3.01 | 3.65 | 3.60 | 3.53 | 3.58 | 0.65 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Interest Paid Net | 2.29 | 1.90 | 2.45 | 1.88 | 2.76 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Allocated Share Based Compensation Expense | 14.30 | 15.56 | 15.34 | 17.34 | 14.67 | 14.29 | 14.14 | 14.18 | 12.86 | 11.88 | 11.64 | 11.20 | 8.50 | 7.30 | 6.50 | 6.40 | 4.70 | 3.40 | 3.30 | 3.30 | 3.00 | 3.00 | 2.60 | 2.40 | |
| Profit Loss | -47.53 | -69.47 | -50.33 | -47.81 | -57.70 | -40.17 | -45.32 | -52.08 | -62.80 | -61.36 | -56.00 | -49.30 | -40.64 | -44.57 | -36.72 | -33.53 | -31.40 | -20.61 | -13.95 | -15.66 | -18.39 | -13.27 | -8.29 | NA | |
| Net Income Loss | -47.51 | -69.44 | -50.30 | -47.81 | -57.70 | -40.13 | -45.28 | -52.05 | -62.74 | -61.43 | -55.90 | -49.30 | -40.64 | -44.57 | -36.72 | -33.53 | -31.40 | -20.61 | -13.95 | -15.66 | -18.39 | -13.27 | -8.29 | -12.49 | |
| Comprehensive Income Net Of Tax | -47.83 | -68.98 | -49.66 | -46.80 | -55.49 | -38.27 | -45.45 | -53.06 | -66.38 | -62.58 | -56.11 | -49.72 | -40.90 | -45.10 | -37.45 | -34.70 | -28.76 | -20.51 | -13.76 | -15.37 | -18.19 | -13.18 | -8.25 | -12.45 |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | 620.32 | 661.13 | 717.68 | 764.54 | 791.46 | 856.62 | 884.21 | 806.63 | 858.19 | 923.34 | 992.61 | 1033.37 | 1072.09 | 1116.41 | 1095.47 | 854.82 | 874.89 | 912.30 | 917.39 | 601.39 | NA | 332.69 | NA | NA | |
| Liabilities | 345.56 | 352.86 | 356.05 | 368.57 | 367.51 | 392.52 | 396.39 | 288.32 | 304.94 | 319.24 | 341.06 | 340.06 | 346.38 | 373.15 | 320.43 | 324.88 | 323.32 | 341.26 | 331.47 | 323.84 | NA | 29.94 | NA | NA | |
| Liabilities And Stockholders Equity | 620.32 | 661.13 | 717.68 | 764.54 | 791.46 | 856.62 | 884.21 | 806.63 | 858.19 | 923.34 | 992.61 | 1033.37 | 1072.09 | 1116.41 | 1095.47 | 854.82 | 874.89 | 912.30 | 917.39 | 601.39 | NA | 332.69 | NA | NA | |
| Stockholders Equity | 274.91 | 308.40 | 361.73 | 396.04 | 424.02 | 464.17 | 487.84 | 518.30 | 553.21 | 603.99 | 651.51 | 693.18 | 725.59 | 743.27 | 775.05 | 529.94 | 551.56 | 571.04 | 585.92 | -284.37 | -273.47 | -258.11 | -248.08 | -242.44 |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets Current | 374.03 | 410.19 | 435.24 | 476.81 | 501.33 | 562.15 | 564.38 | 438.57 | 419.12 | 402.75 | 467.03 | 643.73 | 764.96 | 726.91 | 877.36 | 599.52 | 584.65 | 612.69 | 601.36 | 442.30 | NA | 180.72 | NA | NA | |
| Cash And Cash Equivalents At Carrying Value | 71.23 | 65.06 | 88.71 | 109.24 | 94.61 | 90.03 | 217.55 | 76.41 | 114.81 | 139.06 | 122.40 | 184.19 | 173.62 | 123.44 | 497.08 | 365.44 | 212.69 | 96.58 | 74.94 | 48.46 | NA | 55.03 | NA | NA | |
| Accounts Receivable Net Current | 42.02 | 37.97 | 31.21 | 31.55 | 30.97 | 40.06 | 26.55 | 23.71 | 22.52 | 17.41 | 17.12 | 14.17 | 19.75 | 10.05 | 11.86 | 7.91 | 9.38 | 12.68 | 9.26 | 7.25 | NA | 4.81 | NA | NA | |
| Inventory Net | 13.29 | 14.45 | 19.49 | 18.96 | 19.87 | 14.45 | 17.34 | 18.78 | 21.00 | 19.26 | 18.23 | 18.61 | 17.42 | 14.06 | 10.74 | 10.54 | 10.52 | 9.07 | 8.67 | 8.00 | NA | 7.84 | NA | NA | |
| Prepaid Expense And Other Assets Current | 9.85 | 11.37 | 13.40 | 9.07 | 9.79 | 9.44 | 12.41 | 12.35 | 12.04 | 13.02 | 16.63 | 12.53 | 13.52 | 14.54 | 19.68 | 10.69 | 9.57 | 14.08 | 10.00 | 4.04 | NA | 3.06 | NA | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Property Plant And Equipment Gross | NA | 141.46 | NA | NA | NA | 137.80 | NA | NA | NA | 121.49 | NA | NA | NA | 64.07 | NA | NA | NA | 78.47 | NA | NA | NA | 31.58 | NA | NA | |
| Leasehold Improvements Gross | NA | 14.80 | NA | NA | NA | 14.80 | NA | NA | NA | 14.80 | NA | NA | NA | 14.80 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | NA | 73.23 | NA | NA | NA | 54.35 | NA | NA | NA | 36.23 | NA | NA | NA | 24.38 | NA | NA | NA | 18.12 | NA | NA | NA | 12.45 | NA | NA | |
| Amortization Of Intangible Assets | 0.42 | 0.43 | 0.43 | 0.42 | 0.42 | 0.43 | 0.43 | 0.42 | 0.42 | 0.43 | 0.43 | 0.42 | 0.42 | 0.43 | 0.43 | 0.42 | 0.42 | 0.43 | 0.43 | 0.42 | 0.42 | 0.43 | 0.43 | 0.42 | |
| Property Plant And Equipment Net | 65.26 | 68.23 | 76.75 | 79.39 | 81.29 | 83.45 | 86.66 | 86.85 | 85.99 | 85.26 | 87.82 | 75.23 | 56.31 | 39.69 | 31.16 | 26.83 | 24.95 | 60.35 | 46.54 | 22.30 | NA | 19.12 | NA | NA | |
| Goodwill | 118.97 | 118.97 | 118.97 | 118.97 | 118.97 | 118.97 | 118.97 | 118.97 | 118.97 | 118.97 | 118.97 | 118.97 | 118.97 | 118.97 | 118.97 | 118.97 | 118.97 | 118.97 | 118.97 | 118.97 | NA | 118.97 | NA | NA | |
| Finite Lived Intangible Assets Net | 4.71 | 5.13 | 5.56 | 5.99 | 6.41 | 6.83 | 7.26 | 7.68 | 8.11 | 8.53 | 8.96 | 9.38 | 9.81 | 10.22 | 10.65 | 11.08 | 11.50 | 11.93 | 12.36 | 12.78 | NA | 13.63 | NA | NA | |
| Other Assets Noncurrent | 3.39 | 3.59 | 2.98 | 3.35 | 2.18 | 2.06 | 2.20 | 0.78 | 0.87 | 0.88 | 0.87 | 0.72 | 0.72 | 0.60 | 1.00 | 1.27 | 1.00 | 0.78 | 0.72 | NA | NA | 0.19 | NA | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities Current | 82.95 | 88.02 | 93.30 | 95.33 | 90.10 | 109.79 | 104.02 | 111.47 | 115.07 | 113.81 | 122.38 | 116.65 | 106.77 | 105.20 | 100.83 | 93.42 | 77.95 | 78.31 | 73.38 | 74.86 | NA | 22.80 | NA | NA | |
| Accounts Payable Current | 12.17 | 7.72 | 4.48 | 9.16 | 6.33 | 8.08 | 4.16 | 2.72 | 5.96 | 3.31 | 8.25 | 6.09 | 5.20 | 3.24 | 5.41 | 3.69 | 3.90 | 4.45 | 2.42 | 2.94 | NA | 1.79 | NA | NA | |
| Other Accrued Liabilities Current | NA | 0.76 | NA | NA | NA | 1.66 | NA | NA | NA | 2.82 | NA | NA | NA | 1.88 | NA | NA | NA | 0.48 | NA | NA | NA | 0.55 | NA | NA | |
| Accrued Income Taxes Current | NA | 0.06 | NA | NA | NA | 0.19 | NA | NA | NA | 0.39 | NA | NA | NA | 1.77 | NA | NA | NA | 2.06 | NA | NA | NA | 0.11 | NA | NA | |
| Accrued Liabilities Current | 7.91 | 8.60 | 10.15 | 8.36 | 8.04 | 12.42 | 10.70 | 9.45 | 10.41 | 9.34 | 17.03 | 13.54 | 13.48 | 13.16 | 5.35 | 4.83 | 3.80 | 4.37 | 3.38 | 5.02 | NA | 2.56 | NA | NA | |
| Contract With Customer Liability Current | 46.87 | 48.63 | 55.34 | 57.92 | 60.32 | 64.11 | 67.89 | 80.91 | 83.50 | 80.46 | 79.95 | 83.55 | 78.35 | 73.32 | 78.19 | 75.70 | 64.57 | 60.99 | 61.27 | 61.19 | NA | 12.70 | NA | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long Term Debt Noncurrent | 131.54 | 130.66 | 126.73 | NA | NA | 125.36 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Minority Interest | -0.15 | -0.12 | -0.10 | -0.07 | -0.07 | -0.07 | -0.03 | 0.01 | 0.05 | 0.11 | 0.03 | 0.13 | 0.13 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Operating Lease Liability Noncurrent | 86.90 | 89.39 | 91.82 | 94.18 | 96.49 | 98.77 | 100.52 | 102.73 | 104.98 | 106.69 | 108.04 | 103.77 | 95.25 | 104.33 | 42.37 | 42.50 | 36.55 | NA | NA | NA | NA | NA | NA | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | 274.91 | 308.40 | 361.73 | 396.04 | 424.02 | 464.17 | 487.84 | 518.30 | 553.21 | 603.99 | 651.51 | 693.18 | 725.59 | 743.27 | 775.05 | 529.94 | 551.56 | 571.04 | 585.92 | -284.37 | -273.47 | -258.11 | -248.08 | -242.44 | |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 274.77 | 308.28 | 361.64 | 395.97 | 423.95 | 464.10 | 487.81 | 518.32 | 553.25 | 604.10 | 651.54 | 693.31 | 725.72 | 743.27 | 775.05 | 529.94 | 551.56 | 571.04 | NA | NA | NA | -258.11 | NA | NA | |
| Common Stock Value | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | NA | 0.00 | NA | NA | |
| Additional Paid In Capital | 1466.84 | 1452.50 | 1436.86 | 1421.51 | 1402.69 | 1387.35 | 1372.75 | 1357.76 | 1339.60 | 1324.01 | 1308.95 | 1294.51 | 1277.20 | 1253.97 | 1240.65 | 958.10 | 945.03 | 935.83 | 930.21 | NA | NA | 37.90 | NA | NA | |
| Retained Earnings Accumulated Deficit | -1191.84 | -1144.33 | -1074.89 | -1024.59 | -976.78 | -919.08 | -878.95 | -833.67 | -781.63 | -718.89 | -657.46 | -601.55 | -552.25 | -511.61 | -467.04 | -430.32 | -396.79 | -365.48 | -344.87 | -330.92 | NA | -295.91 | NA | NA | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0.11 | 0.21 | -0.25 | -0.89 | -1.91 | -4.12 | -5.97 | -5.80 | -4.78 | -1.14 | 0.01 | 0.22 | 0.63 | 0.89 | 1.43 | 2.15 | 3.31 | 0.67 | 0.57 | 0.38 | NA | -0.11 | NA | NA | |
| Minority Interest | -0.15 | -0.12 | -0.10 | -0.07 | -0.07 | -0.07 | -0.03 | 0.01 | 0.05 | 0.11 | 0.03 | 0.13 | 0.13 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 14.30 | 15.56 | 15.34 | 17.34 | 14.67 | 14.29 | 14.14 | 14.18 | 12.86 | 11.88 | 11.64 | 11.25 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -38.35 | -26.93 | -46.68 | -23.56 | -59.15 | -30.02 | -42.41 | -47.06 | -64.45 | -53.83 | -43.44 | -37.21 | -58.24 | -39.84 | -47.16 | -31.08 | -31.61 | -26.79 | -30.14 | -15.97 | 278.30 | -5.41 | -11.69 | NA | |
| Net Cash Provided By Used In Investing Activities | 44.51 | 3.21 | 26.14 | 37.32 | 62.98 | -97.54 | 58.02 | 4.75 | 37.69 | 67.21 | -21.27 | 41.45 | 93.82 | -340.05 | -97.25 | 177.49 | 142.76 | 46.68 | -260.85 | -45.35 | -222.18 | 27.63 | 5.13 | NA | |
| Net Cash Provided By Used In Financing Activities | 0.04 | 0.09 | 0.02 | 1.47 | 0.67 | 0.01 | 125.52 | 3.99 | 2.75 | 3.28 | 2.93 | 6.33 | 14.61 | 6.25 | 276.04 | 6.34 | 4.96 | 1.75 | 319.55 | -1.50 | 0.12 | 0.28 | 0.06 | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -38.35 | -26.93 | -46.68 | -23.56 | -59.15 | -30.02 | -42.41 | -47.06 | -64.45 | -53.83 | -43.44 | -37.21 | -58.24 | -39.84 | -47.16 | -31.08 | -31.61 | -26.79 | -30.14 | -15.97 | 278.30 | -5.41 | -11.69 | NA | |
| Net Income Loss | -47.51 | -69.44 | -50.30 | -47.81 | -57.70 | -40.13 | -45.28 | -52.05 | -62.74 | -61.43 | -55.90 | -49.30 | -40.64 | -44.57 | -36.72 | -33.53 | -31.40 | -20.61 | -13.95 | -15.66 | -18.39 | -13.27 | -8.29 | -12.49 | |
| Profit Loss | -47.53 | -69.47 | -50.33 | -47.81 | -57.70 | -40.17 | -45.32 | -52.08 | -62.80 | -61.36 | -56.00 | -49.30 | -40.64 | -44.57 | -36.72 | -33.53 | -31.40 | -20.61 | -13.95 | -15.66 | -18.39 | -13.27 | -8.29 | NA | |
| Increase Decrease In Other Operating Capital Net | 0.00 | -0.00 | 0.06 | -0.00 | 0.01 | -0.00 | -0.07 | NA | NA | 0.00 | 0.15 | 0.00 | 0.12 | 0.06 | 0.00 | 0.00 | 0.21 | 0.06 | 0.54 | NA | NA | -0.02 | -0.00 | NA | |
| Increase Decrease In Accounts Receivable | 4.05 | 6.77 | -0.33 | 0.62 | -9.09 | 13.51 | 2.84 | 1.19 | 5.11 | 0.29 | 2.95 | -5.58 | 9.71 | -1.81 | 3.94 | -1.47 | -3.28 | 3.42 | 1.95 | 3.19 | -0.74 | -7.56 | 7.95 | NA | |
| Increase Decrease In Inventories | -1.11 | -3.98 | 0.27 | -0.07 | 6.61 | -3.03 | -0.07 | 0.55 | 1.74 | 1.03 | -0.38 | 1.19 | 3.36 | 3.33 | 0.20 | 0.02 | 1.45 | 0.40 | 0.66 | 0.15 | 0.02 | 0.73 | -0.61 | NA | |
| Share Based Compensation | 14.30 | 15.56 | 15.34 | 17.34 | 14.67 | 14.29 | 14.14 | 14.18 | 12.86 | 11.88 | 11.64 | 11.25 | 8.48 | 7.24 | 6.47 | 6.37 | 4.67 | 3.41 | 3.33 | 3.33 | 3.05 | 3.05 | 2.55 | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Investing Activities | 44.51 | 3.21 | 26.14 | 37.32 | 62.98 | -97.54 | 58.02 | 4.75 | 37.69 | 67.21 | -21.27 | 41.45 | 93.82 | -340.05 | -97.25 | 177.49 | 142.76 | 46.68 | -260.85 | -45.35 | -222.18 | 27.63 | 5.13 | NA | |
| Payments To Acquire Property Plant And Equipment | 1.51 | 1.30 | 2.78 | 3.70 | 2.92 | 2.54 | 5.43 | 5.30 | 3.08 | 9.24 | 14.62 | 22.04 | 15.84 | 9.37 | 4.21 | 2.26 | 2.96 | 2.42 | 3.43 | 1.52 | 3.83 | 2.51 | 2.19 | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Financing Activities | 0.04 | 0.09 | 0.02 | 1.47 | 0.67 | 0.01 | 125.52 | 3.99 | 2.75 | 3.28 | 2.93 | 6.33 | 14.61 | 6.25 | 276.04 | 6.34 | 4.96 | 1.75 | 319.55 | -1.50 | 0.12 | 0.28 | 0.06 | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 41.87 | 45.78 | 37.92 | 48.93 | 37.65 | 55.20 | 47.83 | 43.66 | 38.62 | 37.93 | 39.47 | 38.51 | 38.44 | 30.18 | 26.30 | 20.99 | 20.91 | 24.21 | 26.06 | 22.14 | 12.67 | 17.19 | 17.19 | 11.57 | |
| Operating, Immune Medicine Business | 9.25 | NA | NA | NA | 16.22 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Operating, Mrd Business | 32.63 | NA | NA | NA | 21.43 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Immune Medicine Service Revenue | 4.70 | NA | NA | NA | 9.10 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Collaboration Revenue, Immune Medicine Revenue | 4.69 | 7.91 | 8.01 | 17.54 | 9.12 | 16.28 | 21.32 | 15.08 | 13.70 | 14.51 | 15.45 | 17.63 | 16.06 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Immune Medicine Service Revenue, Medicare Reimbursements | NA | 0.20 | 0.00 | NA | NA | 0.40 | 0.10 | 0.00 | 0.20 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Regulatory Milestone Revenue, M R D Revenue | 4.50 | NA | NA | NA | NA | 2.00 | 0.00 | 1.00 | 3.00 | 0.00 | 1.50 | 1.50 | 7.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Service, Immune Medicine Revenue | 4.56 | 7.11 | 5.24 | 5.51 | 7.10 | 10.81 | 6.56 | 7.30 | 7.11 | 6.86 | 8.17 | 5.41 | 4.05 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Service, M R D Revenue | 28.13 | 30.76 | 24.67 | 25.88 | 21.43 | 26.11 | 19.95 | 20.28 | 14.80 | 16.56 | 14.35 | 13.97 | 11.34 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Genentech Collaboration Agreement | NA | 7.90 | 8.00 | 17.50 | 9.10 | 16.30 | 20.40 | 13.80 | 12.30 | 14.20 | 15.00 | 17.20 | 15.60 | 16.90 | 12.30 | 12.70 | 10.90 | 8.90 | 11.40 | 8.50 | 6.30 | NA | NA | NA | |
| Immune Medicine Revenue | 9.25 | 15.02 | 13.25 | 23.04 | 16.22 | 27.09 | 27.88 | 22.38 | 20.82 | 21.37 | 23.61 | 23.04 | 20.11 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| M R D Revenue | 32.63 | 30.76 | 24.67 | 25.88 | 21.43 | 28.11 | 19.95 | 21.28 | 17.80 | 16.56 | 15.85 | 15.47 | 18.34 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Medicare Reimbursements | 1.50 | 1.00 | 1.90 | 1.30 | 1.00 | 1.50 | 1.10 | 1.40 | 1.40 | 0.40 | 1.50 | 3.10 | 0.80 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Revenue From Contract With Customer Excluding Assessed Tax | 41.87 | 45.78 | 37.92 | 48.93 | 37.65 | 55.20 | 47.83 | 43.66 | 38.62 | 37.93 | 39.47 | 38.51 | 38.44 | 30.18 | 26.30 | 20.99 | 20.91 | 24.21 | 26.06 | 22.14 | 12.67 | 17.19 | 17.19 | 11.57 | |
| Operating, Immune Medicine Business | 9.25 | NA | NA | NA | 16.22 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Operating, Mrd Business | 32.63 | NA | NA | NA | 21.43 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Immune Medicine Service Revenue | 4.70 | NA | NA | NA | 9.10 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Collaboration Revenue, Immune Medicine Revenue | 4.69 | 7.91 | 8.01 | 17.54 | 9.12 | 16.28 | 21.32 | 15.08 | 13.70 | 14.51 | 15.45 | 17.63 | 16.06 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Immune Medicine Service Revenue, Medicare Reimbursements | NA | 0.20 | 0.00 | NA | NA | 0.40 | 0.10 | 0.00 | 0.20 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Regulatory Milestone Revenue, M R D Revenue | 4.50 | NA | NA | NA | NA | 2.00 | 0.00 | 1.00 | 3.00 | 0.00 | 1.50 | 1.50 | 7.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Service, Immune Medicine Revenue | 4.56 | 7.11 | 5.24 | 5.51 | 7.10 | 10.81 | 6.56 | 7.30 | 7.11 | 6.86 | 8.17 | 5.41 | 4.05 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Service, M R D Revenue | 28.13 | 30.76 | 24.67 | 25.88 | 21.43 | 26.11 | 19.95 | 20.28 | 14.80 | 16.56 | 14.35 | 13.97 | 11.34 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Genentech Collaboration Agreement | NA | 7.90 | 8.00 | 17.50 | 9.10 | 16.30 | 20.40 | 13.80 | 12.30 | 14.20 | 15.00 | 17.20 | 15.60 | 16.90 | 12.30 | 12.70 | 10.90 | 8.90 | 11.40 | 8.50 | 6.30 | NA | NA | NA | |
| Immune Medicine Revenue | 9.25 | 15.02 | 13.25 | 23.04 | 16.22 | 27.09 | 27.88 | 22.38 | 20.82 | 21.37 | 23.61 | 23.04 | 20.11 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| M R D Revenue | 32.63 | 30.76 | 24.67 | 25.88 | 21.43 | 28.11 | 19.95 | 21.28 | 17.80 | 16.56 | 15.85 | 15.47 | 18.34 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Medicare Reimbursements | 1.50 | 1.00 | 1.90 | 1.30 | 1.00 | 1.50 | 1.10 | 1.40 | 1.40 | 0.40 | 1.50 | 3.10 | 0.80 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
